Peptides
Cagrisema
0105
Cagrisema is a research-grade blend combining semaglutide (GLP-1 receptor agonist) and cagrilintide (amylin analog). This combination is studied for the complementary mechanisms of incretin and amylin pathway co-activation in metabolic research models.
≥98%
Size
10mg$131.9910 available
$131.99
Members pay $119.99 · free shipping · no card feesIn StockSpecifications
- Purity
- ≥98%
- Molecular Weight
- Blend
- Sequence
- Semaglutide + Cagrilintide blend
- Form
- Lyophilized powder
- Storage
- Store lyophilized at -20°C. Reconstituted solution stable at 2-8°C for up to 14 days.
This product is intended for laboratory research use only. Not for human consumption, therapeutic, or diagnostic use.